Global Solid-phase Oligonucleotide Synthesis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 100

Published Date: 01 Apr 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Solid-phase Oligonucleotide Synthesis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Solid-phase Oligonucleotide Synthesis market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Commercial accounting for  % of the Solid-phase Oligonucleotide Synthesis global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Primers segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Solid-phase Oligonucleotide Synthesis include Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), and OriGene, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Solid-phase Oligonucleotide Synthesis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Primers
    Probes
    Intermediate-scale Synthesis Oligos
    Large-scale Synthesis Oligos
    Linkers and Adaptors

Market segment by Application, can be divided into
    Commercial
    Academic Research

Market segment by players, this report covers
    Genescript
    GeneArt (Thermofischer)
    Renesas Electronics Corporation
    DNA 2.0 (ATUM)
    OriGene
    BBI
    Genewiz
    Eurofins Genomics
    Gene Oracle
    SBS Genetech
    Bio Basic

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Solid-phase Oligonucleotide Synthesis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Solid-phase Oligonucleotide Synthesis, with revenue, gross margin and global market share of Solid-phase Oligonucleotide Synthesis from 2019 to 2022.
Chapter 3, the Solid-phase Oligonucleotide Synthesis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Solid-phase Oligonucleotide Synthesis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Solid-phase Oligonucleotide Synthesis research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Solid-phase Oligonucleotide Synthesis
    1.2 Classification of Solid-phase Oligonucleotide Synthesis by Type
        1.2.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type in 2021
        1.2.3 Primers
        1.2.4 Probes
        1.2.5 Intermediate-scale Synthesis Oligos
        1.2.6 Large-scale Synthesis Oligos
        1.2.7 Linkers and Adaptors
    1.3 Global Solid-phase Oligonucleotide Synthesis Market by Application
        1.3.1 Overview: Global Solid-phase Oligonucleotide Synthesis Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Commercial
        1.3.3 Academic Research
    1.4 Global Solid-phase Oligonucleotide Synthesis Market Size & Forecast
    1.5 Global Solid-phase Oligonucleotide Synthesis Market Size and Forecast by Region
        1.5.1 Global Solid-phase Oligonucleotide Synthesis Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Solid-phase Oligonucleotide Synthesis Market Size by Region, (2017-2022)
        1.5.3 North America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2017-2028)
        1.5.4 Europe Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2017-2028)
        1.5.6 South America Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Solid-phase Oligonucleotide Synthesis Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Solid-phase Oligonucleotide Synthesis Market Drivers
        1.6.2 Solid-phase Oligonucleotide Synthesis Market Restraints
        1.6.3 Solid-phase Oligonucleotide Synthesis Trends Analysis

2 Company Profiles
    2.1 Genescript
        2.1.1 Genescript Details
        2.1.2 Genescript Major Business
        2.1.3 Genescript Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.1.4 Genescript Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Genescript Recent Developments and Future Plans
    2.2 GeneArt (Thermofischer)
        2.2.1 GeneArt (Thermofischer) Details
        2.2.2 GeneArt (Thermofischer) Major Business
        2.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.2.4 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 GeneArt (Thermofischer) Recent Developments and Future Plans
    2.3 Renesas Electronics Corporation
        2.3.1 Renesas Electronics Corporation Details
        2.3.2 Renesas Electronics Corporation Major Business
        2.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.3.4 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Renesas Electronics Corporation Recent Developments and Future Plans
    2.4 DNA 2.0 (ATUM)
        2.4.1 DNA 2.0 (ATUM) Details
        2.4.2 DNA 2.0 (ATUM) Major Business
        2.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.4.4 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 DNA 2.0 (ATUM) Recent Developments and Future Plans
    2.5 OriGene
        2.5.1 OriGene Details
        2.5.2 OriGene Major Business
        2.5.3 OriGene Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.5.4 OriGene Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 OriGene Recent Developments and Future Plans
    2.6 BBI
        2.6.1 BBI Details
        2.6.2 BBI Major Business
        2.6.3 BBI Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.6.4 BBI Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 BBI Recent Developments and Future Plans
    2.7 Genewiz
        2.7.1 Genewiz Details
        2.7.2 Genewiz Major Business
        2.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.7.4 Genewiz Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Genewiz Recent Developments and Future Plans
    2.8 Eurofins Genomics
        2.8.1 Eurofins Genomics Details
        2.8.2 Eurofins Genomics Major Business
        2.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.8.4 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Eurofins Genomics Recent Developments and Future Plans
    2.9 Gene Oracle
        2.9.1 Gene Oracle Details
        2.9.2 Gene Oracle Major Business
        2.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.9.4 Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Gene Oracle Recent Developments and Future Plans
    2.10 SBS Genetech
        2.10.1 SBS Genetech Details
        2.10.2 SBS Genetech Major Business
        2.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.10.4 SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 SBS Genetech Recent Developments and Future Plans
    2.11 Bio Basic
        2.11.1 Bio Basic Details
        2.11.2 Bio Basic Major Business
        2.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Product and Solutions
        2.11.4 Bio Basic Solid-phase Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Bio Basic Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Solid-phase Oligonucleotide Synthesis Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Solid-phase Oligonucleotide Synthesis Players Market Share in 2021
        3.2.2 Top 10 Solid-phase Oligonucleotide Synthesis Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Solid-phase Oligonucleotide Synthesis Players Head Office, Products and Services Provided
    3.4 Solid-phase Oligonucleotide Synthesis Mergers & Acquisitions
    3.5 Solid-phase Oligonucleotide Synthesis New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Solid-phase Oligonucleotide Synthesis Revenue and Market Share by Type (2017-2022)
    4.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application (2017-2022)
    5.2 Global Solid-phase Oligonucleotide Synthesis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2028)
    6.2 North America Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2028)
    6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
        6.3.1 North America Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2028)
        6.3.2 United States Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        6.3.3 Canada Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        6.3.4 Mexico Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2028)
    7.2 Europe Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2028)
    7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
        7.3.1 Europe Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2028)
        7.3.2 Germany Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        7.3.3 France Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        7.3.5 Russia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        7.3.6 Italy Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2028)
    8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2028)
    8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region
        8.3.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Region (2017-2028)
        8.3.2 China Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        8.3.3 Japan Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        8.3.4 South Korea Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        8.3.5 India Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        8.3.7 Australia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2028)
    9.2 South America Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2028)
    9.3 South America Solid-phase Oligonucleotide Synthesis Market Size by Country
        9.3.1 South America Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2028)
        9.3.2 Brazil Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        9.3.3 Argentina Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2028)
    10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2028)
    10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country
        10.3.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2028)
        10.3.2 Turkey Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)
        10.3.4 UAE Solid-phase Oligonucleotide Synthesis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Solid-phase Oligonucleotide Synthesis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Solid-phase Oligonucleotide Synthesis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Solid-phase Oligonucleotide Synthesis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Solid-phase Oligonucleotide Synthesis Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2023-2028)
    Table 6. Genescript Corporate Information, Head Office, and Major Competitors
    Table 7. Genescript Major Business
    Table 8. Genescript Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 9. Genescript Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. GeneArt (Thermofischer) Corporate Information, Head Office, and Major Competitors
    Table 11. GeneArt (Thermofischer) Major Business
    Table 12. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 13. GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Renesas Electronics Corporation Corporate Information, Head Office, and Major Competitors
    Table 15. Renesas Electronics Corporation Major Business
    Table 16. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 17. Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. DNA 2.0 (ATUM) Corporate Information, Head Office, and Major Competitors
    Table 19. DNA 2.0 (ATUM) Major Business
    Table 20. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 21. DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. OriGene Corporate Information, Head Office, and Major Competitors
    Table 23. OriGene Major Business
    Table 24. OriGene Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 25. OriGene Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. BBI Corporate Information, Head Office, and Major Competitors
    Table 27. BBI Major Business
    Table 28. BBI Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 29. BBI Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Genewiz Corporate Information, Head Office, and Major Competitors
    Table 31. Genewiz Major Business
    Table 32. Genewiz Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 33. Genewiz Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Eurofins Genomics Corporate Information, Head Office, and Major Competitors
    Table 35. Eurofins Genomics Major Business
    Table 36. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 37. Eurofins Genomics Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Gene Oracle Corporate Information, Head Office, and Major Competitors
    Table 39. Gene Oracle Major Business
    Table 40. Gene Oracle Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 41. Gene Oracle Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. SBS Genetech Corporate Information, Head Office, and Major Competitors
    Table 43. SBS Genetech Major Business
    Table 44. SBS Genetech Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 45. SBS Genetech Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Bio Basic Corporate Information, Head Office, and Major Competitors
    Table 47. Bio Basic Major Business
    Table 48. Bio Basic Solid-phase Oligonucleotide Synthesis Product and Solutions
    Table 49. Bio Basic Solid-phase Oligonucleotide Synthesis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. Global Solid-phase Oligonucleotide Synthesis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 51. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 52. Breakdown of Solid-phase Oligonucleotide Synthesis by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. Solid-phase Oligonucleotide Synthesis Players Head Office, Products and Services Provided
    Table 54. Solid-phase Oligonucleotide Synthesis Mergers & Acquisitions in the Past Five Years
    Table 55. Solid-phase Oligonucleotide Synthesis New Entrants and Expansion Plans
    Table 56. Global Solid-phase Oligonucleotide Synthesis Revenue (USD Million) by Type (2017-2022)
    Table 57. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Type (2017-2022)
    Table 58. Global Solid-phase Oligonucleotide Synthesis Revenue Forecast by Type (2023-2028)
    Table 59. Global Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022)
    Table 60. Global Solid-phase Oligonucleotide Synthesis Revenue Forecast by Application (2023-2028)
    Table 61. North America Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2022) & (USD Million)
    Table 62. North America Solid-phase Oligonucleotide Synthesis Revenue by Type (2023-2028) & (USD Million)
    Table 63. North America Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022) & (USD Million)
    Table 64. North America Solid-phase Oligonucleotide Synthesis Revenue by Application (2023-2028) & (USD Million)
    Table 65. North America Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2022) & (USD Million)
    Table 66. North America Solid-phase Oligonucleotide Synthesis Revenue by Country (2023-2028) & (USD Million)
    Table 67. Europe Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2022) & (USD Million)
    Table 68. Europe Solid-phase Oligonucleotide Synthesis Revenue by Type (2023-2028) & (USD Million)
    Table 69. Europe Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022) & (USD Million)
    Table 70. Europe Solid-phase Oligonucleotide Synthesis Revenue by Application (2023-2028) & (USD Million)
    Table 71. Europe Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2022) & (USD Million)
    Table 72. Europe Solid-phase Oligonucleotide Synthesis Revenue by Country (2023-2028) & (USD Million)
    Table 73. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2022) & (USD Million)
    Table 74. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Type (2023-2028) & (USD Million)
    Table 75. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022) & (USD Million)
    Table 76. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Application (2023-2028) & (USD Million)
    Table 77. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Region (2017-2022) & (USD Million)
    Table 78. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue by Region (2023-2028) & (USD Million)
    Table 79. South America Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2022) & (USD Million)
    Table 80. South America Solid-phase Oligonucleotide Synthesis Revenue by Type (2023-2028) & (USD Million)
    Table 81. South America Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022) & (USD Million)
    Table 82. South America Solid-phase Oligonucleotide Synthesis Revenue by Application (2023-2028) & (USD Million)
    Table 83. South America Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2022) & (USD Million)
    Table 84. South America Solid-phase Oligonucleotide Synthesis Revenue by Country (2023-2028) & (USD Million)
    Table 85. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Type (2017-2022) & (USD Million)
    Table 86. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Type (2023-2028) & (USD Million)
    Table 87. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Application (2017-2022) & (USD Million)
    Table 88. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Application (2023-2028) & (USD Million)
    Table 89. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Country (2017-2022) & (USD Million)
    Table 90. Middle East & Africa Solid-phase Oligonucleotide Synthesis Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Solid-phase Oligonucleotide Synthesis Picture
    Figure 2. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Type in 2021
    Figure 3. Primers
    Figure 4. Probes
    Figure 5. Intermediate-scale Synthesis Oligos
    Figure 6. Large-scale Synthesis Oligos
    Figure 7. Linkers and Adaptors
    Figure 8. Solid-phase Oligonucleotide Synthesis Revenue Market Share by Application in 2021
    Figure 9. Commercial Picture
    Figure 10. Academic Research Picture
    Figure 11. Global Solid-phase Oligonucleotide Synthesis Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 12. Global Solid-phase Oligonucleotide Synthesis Revenue and Forecast (2017-2028) & (USD Million)
    Figure 13. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2017-2028)
    Figure 14. Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region in 2021
    Figure 15. North America Solid-phase Oligonucleotide Synthesis Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 16. Europe Solid-phase Oligonucleotide Synthesis Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 17. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. South America Solid-phase Oligonucleotide Synthesis Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Middle East and Africa Solid-phase Oligonucleotide Synthesis Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. Solid-phase Oligonucleotide Synthesis Market Drivers
    Figure 21. Solid-phase Oligonucleotide Synthesis Market Restraints
    Figure 22. Solid-phase Oligonucleotide Synthesis Market Trends
    Figure 23. Genescript Recent Developments and Future Plans
    Figure 24. GeneArt (Thermofischer) Recent Developments and Future Plans
    Figure 25. Renesas Electronics Corporation Recent Developments and Future Plans
    Figure 26. DNA 2.0 (ATUM) Recent Developments and Future Plans
    Figure 27. OriGene Recent Developments and Future Plans
    Figure 28. BBI Recent Developments and Future Plans
    Figure 29. Genewiz Recent Developments and Future Plans
    Figure 30. Eurofins Genomics Recent Developments and Future Plans
    Figure 31. Gene Oracle Recent Developments and Future Plans
    Figure 32. SBS Genetech Recent Developments and Future Plans
    Figure 33. Bio Basic Recent Developments and Future Plans
    Figure 34. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Players in 2021
    Figure 35. Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 36. Global Top 3 Players Solid-phase Oligonucleotide Synthesis Revenue Market Share in 2021
    Figure 37. Global Top 10 Players Solid-phase Oligonucleotide Synthesis Revenue Market Share in 2021
    Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 39. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Type in 2021
    Figure 40. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Type (2023-2028)
    Figure 41. Global Solid-phase Oligonucleotide Synthesis Revenue Share by Application in 2021
    Figure 42. Global Solid-phase Oligonucleotide Synthesis Market Share Forecast by Application (2023-2028)
    Figure 43. North America Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2017-2028)
    Figure 44. North America Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2017-2028)
    Figure 45. North America Solid-phase Oligonucleotide Synthesis Revenue Market Share by Country (2017-2028)
    Figure 46. United States Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 47. Canada Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 48. Mexico Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 49. Europe Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2017-2028)
    Figure 50. Europe Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2017-2028)
    Figure 51. Europe Solid-phase Oligonucleotide Synthesis Revenue Market Share by Country (2017-2028)
    Figure 52. Germany Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 53. France Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 54. United Kingdom Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 55. Russia Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 56. Italy Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 57. Asia-Pacific Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2017-2028)
    Figure 58. Asia-Pacific Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2017-2028)
    Figure 59. Asia-Pacific Solid-phase Oligonucleotide Synthesis Revenue Market Share by Region (2017-2028)
    Figure 60. China Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Japan Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. South Korea Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 63. India Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 64. Southeast Asia Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 65. Australia Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. South America Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2017-2028)
    Figure 67. South America Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2017-2028)
    Figure 68. South America Solid-phase Oligonucleotide Synthesis Revenue Market Share by Country (2017-2028)
    Figure 69. Brazil Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Argentina Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 71. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales Market Share by Type (2017-2028)
    Figure 72. Middle East and Africa Solid-phase Oligonucleotide Synthesis Sales Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa Solid-phase Oligonucleotide Synthesis Revenue Market Share by Country (2017-2028)
    Figure 74. Turkey Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. Saudi Arabia Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. UAE Solid-phase Oligonucleotide Synthesis Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Methodology
    Figure 78. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Genescript
GeneArt (Thermofischer)
Renesas Electronics Corporation
DNA 2.0 (ATUM)
OriGene
BBI
Genewiz
Eurofins Genomics
Gene Oracle
SBS Genetech
Bio Basic

Product Tags

solid phase oligonucleotide synthesis

Solid-phase Oligonucleotide Synthesis

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>